Modified Rankin Scale (mRS)
iatroX editorial team · Updated · Record checked · editorial policy
The modified Rankin Scale is the standard disability outcome measure in stroke medicine. It grades global disability from 0 (no symptoms) to 5 (severe disability/bedridden) and 6 (dead). It is the primary endpoint in most major stroke trials.
inputs
evidence
derivation
Originally described by Rankin (1957) as a 5-point scale, modified by van Swieten et al. (1988) and Bonita and Beaglehole (1988) to include grade 0 (no symptoms) and grade 6 (death).
validation
The mRS is the most widely used stroke outcome measure in clinical trials globally. Inter-rater reliability is moderate (κ ~0.56) but improves substantially with structured interview (κ ~0.78). Used as the primary endpoint in landmark trials including ECASS, MR CLEAN, DAWN, and DEFUSE-3.
guideline endorsements
AHA/ASA stroke outcome guidelines reference mRS. Stroke trial reporting standards mandate mRS. EAN/ESO stroke guidelines use mRS.
references
- van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.PMID: 3363593
- Wilson JTL, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33(9):2243-2246.PMID: 12215594
- Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale. Stroke. 2007;38(3):1091-1096.PMID: 17272767